Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Association between CHFR methylation and chemosensitivity of paclitaxel in advanced gastric cancer.

× No keyword cloud information.

3 in total

1. The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer.

Authors: Yasuo Koga; Yoshihiko Kitajima; Atsushi Miyoshi; Ken Sato; Seiji Sato; Kohji Miyazaki
Journal: J Gastroenterol Date: 2006-02 Impact factor: 7.527

2. DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer.

Authors: Kazuhiro Yoshida; Yoichi Hamai; Takahisa Suzuki; Yuichi Sanada; Naohide Oue; Wataru Yasui
Journal: Anticancer Res Date: 2006 Jan-Feb Impact factor: 2.480

Review 3. Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine.

Authors: Sarah Derks; Arjen H G Cleven; Veerle Melotte; Kim M Smits; Johann C Brandes; Nilofer Azad; Wim van Criekinge; Adriaan P de Bruïne; James G Herman; Manon van Engeland
Journal: Cancer Metastasis Rev Date: 2014-03 Impact factor: 9.264

3 in total

7 in total

1. High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing.

Authors: Jorge L Sepulveda; Jorge L Gutierrez-Pajares; Aesis Luna; Yuan Yao; John W Tobias; Steven Thomas; Yanghee Woo; Federico Giorgi; Elena V Komissarova; Andrea Califano; Timothy C Wang; Antonia R Sepulveda
Journal: Mod Pathol Date: 2016-01-15 Impact factor: 7.842

2. Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.

Authors: Lutz Krause; Katia Nones; Kelly A Loffler; Derek Nancarrow; Harald Oey; Yue Hang Tang; Nicola J Wayte; Ann Marie Patch; Kalpana Patel; Sandra Brosda; Suzanne Manning; Guy Lampe; Andrew Clouston; Janine Thomas; Jens Stoye; Damian J Hussey; David I Watson; Reginald V Lord; Wayne A Phillips; David Gotley; B Mark Smithers; David C Whiteman; Nicholas K Hayward; Sean M Grimmond; Nicola Waddell; Andrew P Barbour
Journal: Carcinogenesis Date: 2016-02-10 Impact factor: 4.944

3. Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis.

Authors: Hua Shi; Xiaojing Wang; Jianbo Wang; Jundi Pan; Junwei Liu; Bin Ye
Journal: Onco Targets Ther Date: 2016-12-08 Impact factor: 4.147

4. Significant impact of amount of PCR input templates on various PCR-based DNA methylation analysis and countermeasure.

Authors: Zhaojun Liu; Jing Zhou; Liankun Gu; Dajun Deng
Journal: Oncotarget Date: 2016-08-30

5. Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis.

Authors: Yong Ding; Hai-Feng Lian; Yaowu Du
Journal: Oncotarget Date: 2017-12-16

Review 6. CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process.

Authors: Dongjun Dai; Bingluo Zhou; Wenxia Xu; Hongchuan Jin; Xian Wang
Journal: J Cancer Date: 2019-01-29 Impact factor: 4.207

7. CHFR and Paclitaxel Sensitivity of Ovarian Cancer.

Authors: Andrea E Wahner Hendrickson; Daniel W Visscher; Xiaonan Hou; Krista M Goergen; Hunter J Atkinson; Thomas G Beito; Vivian Negron; Wilma L Lingle; Amy K Bruzek; Rachel M Hurley; Jill M Wagner; Karen S Flatten; Kevin L Peterson; Paula A Schneider; Melissa C Larson; Matthew J Maurer; Kimberly R Kalli; Ann L Oberg; S John Weroha; Scott H Kaufmann
Journal: Cancers (Basel) Date: 2021-11-30 Impact factor: 6.639

7 in total